Rapha Capital PE Life Sciences Fund VI

About

Portfolio · 1

FIZE Medical

FIZE Medical develops an AI-powered fluid management platform for critically ill patients, providing real-time urine output monitoring and early detection of acute kidney injury.

2 rounds $50.0M committed Latest: 2026-09

Q&A

What is the primary investment focus of Rapha Capital PE Life Sciences Fund VI?

Rapha Capital PE Life Sciences Fund VI focuses on identifying and investing in mid- and later-stage companies within the life sciences and healthcare sectors that have the potential for transformative impact.

What is Rapha Capital PE Life Sciences Fund VI's investment thesis?

Rapha Capital PE Life Sciences Fund VI's thesis is identifying and growing revolutionary ideas in medicine, healthcare, and technology before others can see their value, with a focus on mid- and later-stage companies in which they can be transformative.

What investment stages does Rapha Capital PE Life Sciences Fund VI target?

Rapha Capital PE Life Sciences Fund VI targets Series A, Post IPO, Mid-stage, and Later-stage investments.

Which sectors does Rapha Capital PE Life Sciences Fund VI prefer to invest in?

Rapha Capital PE Life Sciences Fund VI prefers to invest in Life Sciences, Health Tech & Life Sciences, High Tech, and Enterprise Applications sectors.

What geographies does Rapha Capital PE Life Sciences Fund VI prefer for investments?

Rapha Capital PE Life Sciences Fund VI prefers to invest in the United States and Israel.

What is the name and size of a fund managed by Rapha Capital?

Rapha Capital manages the Rapha Capital BioVentures Fund I, which was established in 2021 with a size of $100,000,000.

Who is a key executive at Rapha Capital PE Life Sciences Fund VI?

Kevin Slawin is the Founder and Managing Partner at Rapha Capital Management, LLC, which manages Rapha Capital PE Life Sciences Fund VI.

What type of investor is Rapha Capital PE Life Sciences Fund VI?

Rapha Capital PE Life Sciences Fund VI is a private equity fund.